Atlas Trials

The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients

Clinical trial NCT03228368 · UNKNOWN

Trial details

NCT number
NCT03228368
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-Small Cell Lung Cancer
Start date
2017-03-01
Primary completion
2018-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.